Should you have the PSA test or not?

Protect yourself with the latest information from Harvard Medical School and navigate your options with confidence.

Protect yourself with the latest information from Harvard Medical School. To ensure delivery of our emails to your inbox, add hhp_info@info.health.harvard.edu to your address book. Please note this is for outgoing mail only. If you need help, please contact hhp_info@health.harvard.edu. View this email as a web page » | Share with a friend » | Unsubscribe » May 11, 2015

Could you suffer complications from prostate treatments you never needed? Protect yourself with the latest information from Harvard Medical School. Dear visitor, Four of the scariest words a man can hear are: “You have prostate cancer.” Prostate cancer is the second most commonly diagnosed cancer in American men and the second-leading cause of cancer death. Sometimes the side effects of treatment, which include erectile dysfunction and incontinence, are worse than the disease. That's because some prostate cancers found using today's high-tech diagnostic techniques would never have caused any health problems or shortened life. That's one reason many doctors are advising men not to have a routine blood test for prostate-specific antigen (PSA) to detect early prostate cancer. How do you decide what’s best for your health? Check out Harvard Medical School’s 2015 Annual Report on Prostate Diseases. This potentially lifesaving report helps you understand why experts are now saying if you don’t have symptoms, don’t get a PSA test. It brings you the latest news on every major prostate disease, from prostate cancer to benign prostatic enlargement (also called BPH) to acute and chronic prostatitis. Click here to discover: • The prostate medication that increases your risk for cancer • How to lower your risk of BPH by 25% • The improved PSA test that saves 20% of men from needing to have a biopsy • How to lower your risk of prostate cancer by nearly 30% • 2 foods that may increase your risk of prostate cancer — and the ones that help prevent it • An effective prostate cancer treatment without risk of erectile dysfunction • 5 new medications that can help men with late-stage cancer. Plus, you’ll get a Special Bonus Section on biomarkers — the future of detecting and treating prostate cancer! You’ll read about a urine-based biomarker that could prevent you from undergoing unnecessary surgery, an FDA-approved test that can help determine if your cancer is high-risk, and even a genetic test that accurately rules out prostate cancer 90% of the time! Harvard Medical School’s 2015 Annual Report on Prostate Diseases is a must-have for all men and the people who love them. That’s why we’re offering it to you right now at 50% OFF the cover price. Click here to learn more. Sincerely, Marc B. Garnick, M.D. Editor in Chief, 2015 Annual Report on Prostate Diseases Clinical Professor of Medicine, Harvard Medical School P.S. You save 50% OFF the cover price and get our 100% Money-Back Satisfaction Guarantee. There’s no risk. Click here for more information.

Harvard Medical School offers special reports on over 50 health topics. Visit our website at http://www.health.harvard.edu to find reports of interest to you and your family. PHONE ORDERS - please call our toll-free number: 1-877-649-9457. You are currently subscribed to HEALTHbeat as dr.samah.saied.ahmed@gmail.com. EDIT YOUR SUBSCRIPTION PROFILE UNSUBSCRIBE SUBSCRIBE TO HEALTHbeat VIEW HEALTHbeat ARCHIVES Visit our website at: www.health.harvard.edu Email us at: healthbeat@health.harvard.edu Follow us on: Copyright © 2015 by Harvard University. Harvard Health Publications, 10 Shattuck Street, 2nd Floor, Boston, MA 02115, USA * Please note, we do not provide responses to personal medical concerns, nor can we supply related medical information other than what is available in our print products or website. For specific, personalized medical advice we encourage you to contact your physician.